4-hydroxyisophthalic acid, compound with glycine, α-ester with D-threo-2,2-dichloro-N-[β-hydroxy-α-(hydroxymethyl)-p-mesylphenethyl]acetamide (1:1) (24557-75-3)
Identification |
Properties |
Safety Data |
|
|
Other Product
- (1α,3α,4α,5β)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid, compound with 4-hydroxy-α-[1-[(1-methyl-2-phenoxyethyl)amino]ethyl]benzenemethanol (1:1)
- 5-oxo-L-proline, compound with [7(S)-(1α,2β,4β,5α,7β)]-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl α-(hydroxymethyl)benzeneacetate (1:1)
- [2S-(2α,5α,6β)]-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, compound with α-phenylbenzylamine
- 1-Naphthalenepropanol, α-ethenyldecahydro-2-hydroxy-α,2,5,5,8a-pentamethyl-, [1R-[1α(R*),2β,4aβ,8aα]]-, oxidized
- [2S-(2α,5α,6β)]-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, compound with 1-ethylpiperidine (1:1)
- 5-ethyl-5-phenylbarbituric acid, compound with [7S-(7α,7aα,14α,14aβ)]-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine
- [2S-(2α,5α,6β)]-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, compound with dibenzylamine
- (1α,2β,4β,6α)-()-2,2,7-trimethyl-3-oxatricyclo[4.1.1.02,4]octane
- (4α,8α,9β,13α,14β,17Z)-16β-acetoxy-3α,11α-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid, compound with 2,2'-iminodiethanol (1:1)
- Acetic acid, [[2-(diethylamino)ethyl]thio]-, 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester, [3aS-(3aα,4β,5α,6α,8β,9α,9aβ,10S*)]-, (E)-2-butenedioate (2:1)
- (1α,2β,4β,5α,7β)-()-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate hydrochloride
- [7(S)-(1α,2β,4β,5α,7β)]-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate
- Acetic acid, [[2-(diethylamino)ethyl]thio]-, 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester, [3aS-(3aα,4β,5α,6α,8β,9α,9aβ,10S*)]-, (E)-2-butenedioate, comp
- phenylglycolic acid, compound with 2-(dimethylamino)ethyl-α-hydroxy-α-phenylbenzeneacetate (1:1)
- α-d-Glucopyranose, O-(N-acetyl-α-neuraminosyl)-(2→3)-O-β-d-galactopyranosyl-(1→4)-, monoammonium salt
- Acetic acid, [(6-hydroxy-4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy]-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamid
- Sulfuric acid, monododecyl ester, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
- (1α,4α,6β)-()-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-ol
- 5-oxo-L-proline, compound with [7S-(7α,7aα,14α,14aβ)]-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine (2:1)
- 5-ethyl-5-phenylbarbituric acid, compound with [7S-(7α,7aα,14α,14aβ)]-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine (2:1)